| Ytd | -3.38% | |
| 1y | 7.69% |
| Open | 444.58 | Prev Close | 445.01 | Low | 443.11 | High | 452.39 | Mkt Cap | 100.07B |
| Vol | 981.15K | Avg Vol | 1.47M | EPS | 30.24 | P/E | 14.92 | Forward P/E | 14.09 |
| Beta | 1.11 | Short Ratio | 4.85 | Inst. Own | 78.87% | Dividend | 3.12 | Div Yield | 0.71 |
| Ex Div Date | 09-16 | Earning | 10-27 | 50-d Avg | 419.61 | 200-d Avg | 445.31 | 1yr Est | 459.27 |
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
HCA Healthcare (NYSE: HCA - Get Free Report) and Nutex Health (NASDAQ: NUTX - Get Free Report) are b
Park National Corp OH lifted its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 54.2% dur
Argent Capital Management LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 36.8% in t
https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-issues-letters-warning-hospitals-aga
HCA Healthcare (NYSE: HCA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are b
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495,
BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and mainta
JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers th
CNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab,
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and ra
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the pri
Multiple members of Congress disclose buying SpaceX stock, even some who aren't big fans of Elon
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target
HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight an
HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and mainta
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowe
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers th
Crude fell about 4% on renewed US-Iran talk hopes, easing yields and fueling a broad rally in real e
Most investors know which stocks they’d like to own. The harder part is deciding when, and at what p
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift an
HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $2
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst cons
Companies Reporting Before The Bell • Charter Communications (NASDAQ:CHTR) is likely to report quart
Market sentiment declines, Nasdaq falls 2%, Trump warns Iran, Tesla and T-Mobile stock drops, while
US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifescie
ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers th
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers
Intuitive Surgical shares slid to a fresh 52-week low Tuesday, caught in a broader pullback across m
HCA Healthcare's preliminary Q2 results showed higher revenue and EPS despite a $400 million hit
HCA Healthcare (NYSE:HCA) Narrows FY2026 sales outlook from $76.500 billion-$80.000 billion to $77.0
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers
HCA Healthcare, Inc. (NYSE:HCA) today announced preliminary financial and operating results for the
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lo
Top Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. HCA
Barclays analyst Andrew Mok downgrades HCA Healthcare (NYSE:HCA) from Overweight to Equal-Weight
Cantor Fitzgerald analyst Sarah James maintains HCA Healthcare (NYSE:HCA) with a Overweight and l
First published data evaluating gene-editing treatment in children ages 5-11 with inherited blood di